A critical discovery in cancer study is arising with the use of mini-antibodies to re-engage dysfunctional p53. This crucial tumor suppressor protein is frequently disabled in various types of cancer, resulting https://seolistlinks.com/story23517757/nanobodies-reactivate-tumor-suppressor-p53-new-promising-approach-for-tumor-management